CRIS Current Research Information System

FIUME, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.135
EU - Europa 1.389
AS - Asia 1.164
AF - Africa 127
SA - Sud America 63
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.124
CN - Cina 446
GB - Regno Unito 380
SG - Singapore 360
IT - Italia 223
DE - Germania 147
VN - Vietnam 145
SE - Svezia 142
UA - Ucraina 124
IN - India 83
HK - Hong Kong 71
RU - Federazione Russa 71
FR - Francia 59
CH - Svizzera 57
TG - Togo 56
BR - Brasile 48
IE - Irlanda 46
ZA - Sudafrica 28
EE - Estonia 25
FI - Finlandia 24
JP - Giappone 24
BG - Bulgaria 19
BE - Belgio 18
NL - Olanda 18
CI - Costa d'Avorio 16
KR - Corea 14
SC - Seychelles 13
NG - Nigeria 10
AR - Argentina 8
HR - Croazia 8
CA - Canada 6
AT - Austria 5
ID - Indonesia 5
JO - Giordania 5
PL - Polonia 5
ES - Italia 4
GR - Grecia 4
AU - Australia 3
RO - Romania 3
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
MX - Messico 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
KE - Kenya 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.884
Salva come PNG Salva come JPEG
Città #
Southend 317
Ashburn 272
Fairfield 240
Singapore 236
Chandler 208
Woodbridge 141
Wilmington 128
Houston 111
Seattle 109
Ann Arbor 106
Santa Clara 95
Jacksonville 81
Hong Kong 71
Princeton 68
Cambridge 67
Beijing 60
Bern 56
Lomé 56
Bologna 51
Hefei 50
Dublin 46
Boardman 41
New York 40
Dong Ket 33
Padova 31
Westminster 30
Los Angeles 26
Tokyo 23
Nanjing 21
Berlin 20
Sofia 19
Brussels 18
Helsinki 18
Shenyang 18
Turin 18
Abidjan 16
Jinan 16
Buffalo 15
Saint Petersburg 15
Nanchang 14
Hangzhou 13
Ho Chi Minh City 13
Mülheim 13
Mahé 12
Seoul 12
Cesenatico 11
Changsha 11
Abeokuta 10
Milan 10
San Diego 10
Falls Church 9
Zhengzhou 9
Dallas 8
Falkenstein 8
Guangzhou 8
Jiaxing 8
Redondo Beach 8
Redwood City 8
Tianjin 8
Hebei 7
Shanghai 7
São Paulo 7
Bengaluru 6
Frankfurt am Main 6
Haikou 6
London 6
Redmond 6
Yubileyny 6
Dearborn 5
Düsseldorf 5
Olalla 5
Phoenix 5
San Jose 5
Sant'agata De' Goti 5
Turku 5
Verona 5
Amman 4
Castel Maggiore 4
Chicago 4
Des Moines 4
Hanoi 4
Kunming 4
Medford 4
Nuremberg 4
Rijeka 4
Salvador 4
Shijiazhuang 4
Taiyuan 4
Taizhou 4
The Dalles 4
Wuhan 4
Brooklyn 3
Cape Town 3
Haiphong 3
Kuban 3
Manchester 3
Moscow 3
Palermo 3
Pescara 3
San Venanzo 3
Totale 3.374
Salva come PNG Salva come JPEG
Nome #
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. 224
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 211
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 206
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 198
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 187
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 184
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 184
Uso di coniugati della doxorubicina con albumina lattosaminata 182
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 177
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 174
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 172
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 172
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 171
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin 170
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 166
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 166
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 160
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 159
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 156
Procedura per la preparazione di coniugati della doxorubicina con l’albumina umana lattosaminata 147
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 146
Albumin-drug conjugates in the treatment of hepatic disorders. 145
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 144
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis 135
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin 130
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. 129
Use of conjugates of doxorubicin with lactosaminated albumin. 117
Lactosaminated human albumin: a hepatotropic carrier of drugs. 115
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 91
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 79
null 78
null 71
Totale 4.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 0 13 23 57 30 28 111
2021/2022634 77 14 51 55 52 29 29 36 23 45 128 95
2022/2023753 81 143 33 89 52 58 14 33 108 10 38 94
2023/2024204 12 31 22 23 6 68 7 11 2 11 3 8
2024/2025606 30 68 47 69 131 42 43 28 7 33 10 98
2025/2026792 124 142 125 133 160 97 11 0 0 0 0 0
Totale 4.946